| Authors: |
Šoltésová M; Swedish NMR Centre, University of Gothenburg, 413 90 Gothenburg, Sweden., Pinon AC; Swedish NMR Centre, University of Gothenburg, 413 90 Gothenburg, Sweden. Electronic address: arthur.pinon@gu.se., Aussenac F; Bruker BioSpin France, Wissembourg, France., Schlagnitweit J; Centre de RMN à Très Hauts Champs de Lyon, UMR5082 CNRS/ENS-Lyon/Université Claude Bernard Lyon 1, Villeurbanne, France., Reiter C; Bruker BioSpin Germany, Ettlingen, Germany., Purea A; Bruker BioSpin Germany, Ettlingen, Germany., Melzi R; Bruker BioSpin Italy, Milan, Italy., Engelke F; Bruker BioSpin Germany, Ettlingen, Germany., Martin D; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Krambeck S; Cell, Gene and RNA Therapy, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Sweden., Biscans A; Cell, Gene and RNA Therapy, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Sweden., Kay E; Assays, Profiling and Cell Sciences, Discovery Sciences, AstraZeneca, Gothenburg, Sweden., Emsley L; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland., Schantz S; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. |
